Cargando…
Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals
BACKGROUND: The recently identified circulating sCD36 has been proposed to reflect tissue CD36 expression, and is upregulated in case of obesity, insulin resistance and hepatic steatosis. The aim of this study was to explore the effect of weight loss secondary to bariatric surgery in relation to sCD...
Autores principales: | Knøsgaard, L, Thomsen, S B, Støckel, M, Vestergaard, H, Handberg, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007154/ https://www.ncbi.nlm.nih.gov/pubmed/24710072 http://dx.doi.org/10.1038/nutd.2014.11 |
Ejemplares similares
-
Circulating CD36 Is Reduced in HNF1A-MODY Carriers
por: Bacon, Siobhan, et al.
Publicado: (2013) -
Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females
por: Touré, Maïmouna, et al.
Publicado: (2022) -
Plasma sCD36 as non-circadian marker of chronic circadian disturbance in shift workers
por: van de Langenberg, Daniella, et al.
Publicado: (2019) -
Maternal adiposity, smoking, and thyroid function in early pregnancy
por: Andersen, Stine Linding, et al.
Publicado: (2021) -
The origin of circulating CD36 in type 2 diabetes
por: Alkhatatbeh, M J, et al.
Publicado: (2013)